Eton Pharmaceuticals (ETON) Return on Capital Employed Growth (1y) (2019 - 2025)
Eton Pharmaceuticals (ETON) Return on Capital Employed Growth (1y) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.88 Bn | 87.01 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.92 Bn | 32.18 Bn | 1.97 Bn | 696.00 |
| 3 | Zoetis | 32.31 Bn | 30.37 Bn | 1.62 Bn | -507.00 |
| 4 | Takeda Pharmaceutical | 27.54 Bn | 23.48 Bn | 4.39 Bn | -723.00 |
| 5 | United Therapeutics | 23.07 Bn | 20.91 Bn | 648.10 Mn | 89.00 |
| 6 | RedHill Biopharma | 20.53 Bn | 20.53 Bn | - | - |
| 7 | Viatris | 20.27 Bn | 18.47 Bn | 1.16 Bn | 944.00 |
| 8 | Neurocrine Biosciences | 17.92 Bn | 16.61 Bn | 800.70 Mn | 448.00 |
| 9 | Elanco Animal Health | 12.61 Bn | 12.18 Bn | 785.00 Mn | 1,195.00 |
| 10 | Eton Pharmaceuticals | 1.16 Bn | 1.14 Bn | 13.10 Mn | 580.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 580.00 |
| Sep 30, 2025 | 3,247.00 |
| Jun 30, 2025 | 4,645.00 |
| Mar 31, 2025 | -754.00 |
| Dec 31, 2024 | 54.00 |
| Sep 30, 2024 | -4,596.00 |
| Jun 30, 2024 | -4,522.00 |
| Mar 31, 2024 | 3,699.00 |
| Dec 31, 2023 | 4,138.00 |
| Sep 30, 2023 | 5,438.00 |
| Jun 30, 2023 | 5,405.00 |
| Mar 31, 2023 | 2,107.00 |
| Dec 31, 2022 | -4,247.00 |
| Sep 30, 2022 | -77.00 |
| Jun 30, 2022 | -1,793.00 |
| Mar 31, 2022 | -432.00 |
| Dec 31, 2021 | 17,333.00 |
| Sep 30, 2021 | 18,434.00 |
| Jun 30, 2021 | 12,162.00 |
| Mar 31, 2021 | 8,157.00 |